News & Events
Filter by Company or Category or search below
Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights
Ocular reported Q2 2026 results, confirming the AXPAXLI wet AMD NDA submission remains on track for Q4 2026 following a positive Type C meeting with the FDA.
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
Imperative Care launched the Ikon 24 Pro Guidewire, enhancing the Zoom Stroke System to support more efficient stroke procedures.
Latest Analysis of Imperative Care’s SYMPHONY-PE Trial Suggests Early Thrombectomy May Improve Key Measures of Heart Recovery in Intermediate-Risk Pulmonary Embolism
A new analysis of the SYMPHONY-PE Trial suggests early thrombectomy may improve key measures of heart recovery in intermediate-risk pulmonary embolism patients.
Imperative Care Appoints Jay Martin as Chief Commercial Officer
Jay Martin was appointed Chief Commercial Officer of Imperative Care.
Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
Ocular reported Q1 2026 results, with a cash balance of $666.7 million and expected runway into 2028, following the positive SOL-1 readout.